Browse Category

NASDAQ:REPER News 29 January 2026

Eli Lilly stock price today: LLY rises on $1.93 billion Repertoire deal as earnings near

Eli Lilly stock price today: LLY rises on $1.93 billion Repertoire deal as earnings near

Eli Lilly shares rose 0.5% Thursday after Repertoire Immune Medicines announced a partnership with the company worth up to $1.93 billion. The deal follows Lilly’s $1.12 billion gene-editing agreement targeting hearing loss. Investors are also watching for Medicare’s plan to include Trulicity in upcoming price negotiations. Lilly’s earnings report is expected Feb. 4.

Stock Market Today

REA Group share price slides after $200m buyback plan — what ASX investors watch next

REA Group share price slides after $200m buyback plan — what ASX investors watch next

8 February 2026
REA Group shares fell 7.8% to A$168.10 after its half-year update showed a 6% rise in EBITDA and a 9% gain in core net profit, but a 24% drop in reported net profit. The company flagged softer listing volumes and announced a A$200 million buyback starting Feb. 23. Interim dividend is A$1.24 per share, ex-dividend March 3. Investors cited pressure from weaker listings and rising costs.
NAB share price in focus after Friday slide as rate rises and bank updates loom

NAB share price in focus after Friday slide as rate rises and bank updates loom

8 February 2026
National Australia Bank shares closed down 1.6% at A$43.36 on Friday after the S&P/ASX 200 fell nearly 2%, its worst session in almost a year. NAB, CBA, and Westpac will raise variable mortgage rates by 0.25% following the Reserve Bank’s hike to 3.85%. Key sector results are due from CBA on Feb. 11, Westpac on Feb. 13, and NAB on Feb. 18.
Go toTop